Abstract
Quality of life is an abstract, multidimensional construct assessing the physical, psychological and social aspects of an individual’s condition. Quality of life measurements are especially pertinent in dermatological conditions due to the high level of psychosocial impact they have on the individual. In epidermolysis bullosa (EB), generic quality of life assessments have been used to compare the burden of EB with other dermatological conditions as well as assess the social, emotional and psychological burden of living with EB. Other more recent studies have developed EB-specific quality of life measurement tools, and qualitative studies have descriptively examined the experience of living with EB. Future uses of quality of life measurements in EB may include assessment of new therapeutic interventions as well as longitudinal quality of life studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Horn HM, Tidman MJ. Quality of life in epidermolysis bullosa. Clin Exp Dermatol. 2002;27:707–10.
Frew JW, Martin LK, Nijsten. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol. 2009;161:1323–30.
WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–9.
World Health Organization. Constitution of the World Health Organization. In: Basic documents. 45th ed. Supplement, October 2006 from the fifty-first world health assembly. Geneva: WHO; 2006; p. 1.
Both H, Essink-Bot M, Bussschbach J, et al. Critical review of generic and dermatology-specific health-related quality of life instruments. J Investig Dermatol. 2010;127:27726–39.
Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56:52–60.
Chren MM, Lasek RJ, Floke SA, et al. Improved discriminative and evaluative capability of a refine version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133:1433–40.
Finlay A, Khan G. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.
Fine JD, Johnson LB, Weiner M, et al. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clin Exp Dermatol. 2004;29:122–7.
Fine JD, Johnson LB, Weiner M, et al. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol. 2005;152:1009–14.
Tabolli S, Sampogna F, Di Pietro C, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol. 2009;161:869–77.
Margari F, Leece PA, Santamato W, et al. Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. J Clin Psychol Med Settings. 2010;17:333–9.
Feldmann R, Weglage J, Frosch M. Cognitive function in patients with epidermolysis bullosa: social adjustment and emotional problems. Klin Padiatr. 2012;224:22–5.
Van Scheppingen C, Lettinga AT, Duipmans JC, et al. Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol. 2008;88:143–50.
Dures E, Morris M, Gleeson K, Rumsey N. The psychosocial impact of epidermolysis bullosa. Qual Health Res. 2011;21:771–8.
Frew DF, Venugopal JW, Murrell SS. Quality of life outcomes of cultured allogeneic fibroblast therapy recipients with epidermolysis bullosa. Aust J Dermatol. 2011;52:S1. p. 26.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Frew, J.W., Murrell, D.F. (2015). Living with Epidermolysis Bullosa: Reviewing the Impact on Individuals’ Quality of Life. In: Murrell, D. (eds) Blistering Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_74
Download citation
DOI: https://doi.org/10.1007/978-3-662-45698-9_74
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45697-2
Online ISBN: 978-3-662-45698-9
eBook Packages: MedicineMedicine (R0)